ストックスクリーナーアプリを入手
177.03
0.63%
-1.07
前日終値:
$178.10
開ける：
$179.98
24時間の取引高:
25,679
Relative Volume:
0.12
時価総額：
$5.12B
収益：
$241.52M
当期純損益:
$52.37M
株価収益率:
-120.43
EPS:
-1.47
ネットキャッシュフロー:
$58.06M
1週間 パフォーマンス:
-0.24%
1か月 パフォーマンス:
-1.12%
6か月 パフォーマンス:
+6.08%
1年 パフォーマンス:
+74.79%
1日の値動き範囲:
$175.09
$179.98
1週間の範囲:
$168.88
$181.69
52週間の値動き範囲:
$99.00
$219.34
Krystal Biotech Inc Stock (KRYS) Company Profile
名前
Krystal Biotech Inc
セクター
電話
(412) 586-5830
住所
2100 WHARTON STREET, PITTSBURGH, PA
KRYS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| KRYS | 176.94 | 5.12B | 241.52M | 52.37M | 58.06M | -1.47 |
| VRTX | 448.94 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.42 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.97 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.31 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.89 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-20 | 開始されました | Goldman | Buy |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-12 | 開始されました | Citigroup | Buy |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-18 | 開始されました | Stifel | Buy |
| 2023-02-28 | アップグレード | Goldman | Neutral → Buy |
| 2022-08-25 | ダウングレード | Goldman | Buy → Neutral |
| 2022-01-18 | 開始されました | BofA Securities | Buy |
| 2021-07-20 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-18 | 開始されました | B. Riley FBR | Buy |
| 2020-06-04 | 開始されました | Evercore ISI | Outperform |
| 2019-09-24 | 開始されました | Goldman | Neutral |
| 2019-08-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-06-24 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-06-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-05-30 | 開始されました | Guggenheim | Buy |
| 2018-09-11 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Krystal Biotech Inc (KRYS) 最新ニュース
Jennison Associates LLC Sells 110,333 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Segall Bryant & Hamill LLC Boosts Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
First Turn Management LLC Has $12.37 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Victory Capital Management Inc. - MarketBeat
Redmile Group, LLC Adjusts Stake in Krystal Biotech Inc - GuruFocus.com
Principal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
(KRYS) Proactive Strategies - Stock Traders Daily
FMR LLC's Strategic Acquisition of Krystal Biotech Inc Shares - GuruFocus.com
High Growth Tech Stocks Featuring Three Prominent US Companies - Simply Wall St
Krystal Biotech Inc (KRYS) Quarterly 10-Q Report - Quartzy
Krystal Biotech to Present at Stifel 2024 Healthcare Conference - StockTitan
Krystal Biotech, Inc. (NASDAQ:KRYS) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Raised by TimesSquare Capital Management LLC - MarketBeat
Janney Montgomery Scott LLC Buys 5,415 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Chardan Capital Predicts Lower Earnings for Krystal Biotech - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Simply Wall St
Q2 EPS Estimates for Krystal Biotech Raised by William Blair - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
HC Wainwright Predicts Reduced Earnings for Krystal Biotech - MarketBeat
HC Wainwright Forecasts Higher Earnings for Krystal Biotech - MarketBeat
Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference - StockTitan
Krystal Biotech FY2024 EPS Forecast Raised by William Blair - MarketBeat
Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction - MSN
Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $206.00 at Citigroup - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Earns "Buy" Rating from HC Wainwright - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Posts Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Q3 2024 Earnings Call Transcript - Insider Monkey
Krystal Biotech Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Krystal stock gains modest boost from Citi, but compliance risks linger - Investing.com Canada
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates - MSN
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Krystal Biotech Faces Challenges in Scaling VYJUVEK Production Amid Regulatory Hurdles - TipRanks
Earnings call: Krystal Biotech reports robust Q3 2024 results By Investing.com - Investing.com Nigeria
Krystal Biotech Reports Strong Q3 2024 Performance - TipRanks
Earnings call: Krystal Biotech reports robust Q3 2024 results - Investing.com India
Krystal Biotech (NASDAQ:KRYS) Shares Gap DownHere's Why - MarketBeat
Krystal Biotech earnings missed by $0.08, revenue topped estimates - Investing.com UK
Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates - The Manila Times
Krystal Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock? - MSN
Where are the Opportunities in (KRYS) - Stock Traders Daily
Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Re - GuruFocus.com
Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Results - Yahoo Finance
Krystal Biotech (KRYS) Set to Announce Quarterly Earnings on Monday - MarketBeat
Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth - MSN
Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024 - The Manila Times
Hennion & Walsh Asset Management Inc. Cuts Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat
Krystal Biotech Inc (KRYS) 財務データ
収益
当期純利益
現金流量
EPS
0.42%
0.16%
大文字化:
|
ボリューム (24 時間):